ask="N/A"
ask_size="N/A"
average_daily_volume="271308"
bid="30.30"
bid_size="900"
book_value="6.19"
change="-0.74"
change_from_200_day_moving_average="-0.18"
change_from_50_day_moving_average="-0.67"
change_from_52_week_high="-8.11"
change_From_52_week_low="15.81"
change_in_percent="-2.35%"
close="30.81"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.06"
ebitda="-175.77M"
eps_estimate_current_year="-3.83"
eps_estimate_next_quarter="-1.03"
eps_estimate_next_year="-3.92"
ex_dividend_date="N/A"
float_shares="29797000"
high="32.02"
high_52_weeks="38.92"
last_trade_date="2/22/2017"
last_trade_price="30.81"
last_trade_size="11507"
last_trade_time="4:00pm"
low="30.39"
low_52_weeks="15.00"
market_capitalization="1.60B"
moving_average_200_day="30.99"
moving_average_50_day="31.48"
name="Theravance Biopharma
Inc."
notes="N/A"
one_year_target_price="34.71"
open="31.38"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-0.58%"
percent_change_from_50_day_moving_average="-2.14%"
percent_change_from_52_week_high="-20.84%"
percent_change_from_52_week_low="+105.40%"
previous_close="31.55"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.09"
price_per_sales="34.98"
revenue="46.85M"
shares_outstanding="51942000"
short_ratio="19.05"
stock_exchange="NGM"
symbol="TBPH"
volume="221054"
weeks_range_52="15.00 - 38.92"
